Benzinga··Erica KollmannBioNTech Stock Crashes 17.67% on Weak Guidance and Founder Exit Plans
BioNTech shares plummeted as the biotech firm issued lower 2026 revenue guidance and co-founders announced plans to exit by year-end 2026.
BNTXstock declinerevenue guidance